Key result
Adenosine-induced dormant accessory pathway conduction after catheter ablation significantly predicted chronic recurrent AP conduction requiring repeat ablation (OR 8.54; 95% CI 1.09-66.9; P=0.041).
Why the study?
Does adenosine administration after successful accessory pathway ablation unmask dormant conduction and predict chronic recurrence?
Observational (n=109)
Does adenosine administration after successful accessory pathway ablation unmask dormant conduction and predict chronic recurrence?
Effect estimate: OR 8.54 (95% CI 1.09-66.9)
p-value: p=0.041
Adenosine administration after successful accessory pathway ablation can unmask dormant conduction, which strongly predicts the need for repeat ablation.
May identify high-risk patients for closer monitoring after accessory pathway ablation; leaves open whether re-ablation of dormant conduction reduces recurrences.
BACKGROUND: Adenosine can unmask dormant pulmonary vein conduction after isolation. The role of adenosine in uncovering dormant accessory pathway (AP) conduction after AP ablation is unknown. METHODS AND RESULTS: We evaluated 109 consecutive patients (age, 41 ± 28 years; 62 [57%] men) who were administered adenosine after successful AP ablation. Dormant AP conduction was defined as adenosine-induced recurrent AP conduction, as demonstrated by recurrent preexcitation or change in retrograde ventriculoatrial activation patterns. Dormant AP conduction was identified in 13 (12%) patients. Adenosine led to transient retrograde AP conduction in 6 patients and transient anterograde AP conduction in 8 patients. In all these cases, adenosine-induced AP conduction occurred during the bradycardia phase of adenosine effect and resulted in dormant AP conduction times shorter than atrioventricular nodal conduction times before adenosine administration. On the basis of analysis of timing of occurrence of dormant AP conduction, the mechanism of adenosine-induced AP conduction was determined to be caused by AP excitability recovery in ≥ 12 (92%) cases. The presence of dormant AP conduction was a significant predictor of chronic recurrent AP conduction requiring repeat ablation (odds ratio, 8.54; 95% confidence interval, 1.09-66.9; P=0.041). CONCLUSIONS: Adenosine can unmask dormant AP conduction after catheter ablation. Direct effects of adenosine on the AP, possibly via AP membrane potential hyperpolarization, are the dominant mechanism of adenosine-induced AP conduction after ablation. Dormant AP conduction is associated with higher rates of recurrent AP conduction requiring repeat ablation.
No takes yet. Share an insight, caveat, or question.
Spotnitz et al. (2014) conducted an observational in Accessory pathway post-ablation (n=109). Adenosine was evaluated on Chronic recurrent AP conduction requiring repeat ablation (OR 8.54, 95% CI 1.09-66.9, p=0.041). Adenosine-induced dormant accessory pathway conduction after catheter ablation significantly predicted chronic recurrent AP conduction requiring repeat ablation (OR 8.54; 95% CI 1.09-66.9; P=0.041).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: